432 related articles for article (PubMed ID: 10365323)
1. Evaluation of anti-tumor efficacy of injectable Centchroman in mice bearing Ehrlich ascites carcinoma.
Shenoy BD; Udupa N; Kamath R; Devi PU
Indian J Physiol Pharmacol; 1999 Apr; 43(2):259-62. PubMed ID: 10365323
[TBL] [Abstract][Full Text] [Related]
2. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice.
Bhattacharya S; Prasanna A; Majumdar P; Kumar RB; Haldar PK
Pharm Biol; 2011 Sep; 49(9):927-35. PubMed ID: 21819262
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anticancer activity of ethanol extract of Sesbania grandiflora (Agati Sesban) against Ehrlich ascites carcinoma in Swiss albino mice.
Sreelatha S; Padma PR; Umasankari E
J Ethnopharmacol; 2011 Apr; 134(3):984-7. PubMed ID: 21251969
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of Hygrophila spinosa on Ehrlich ascites carcinoma and sarcoma-180 induced mice.
Mazumdar UK; Gupta M; Maiti S; Mukherjee D
Indian J Exp Biol; 1997 May; 35(5):473-7. PubMed ID: 9378516
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of anticancer activity of Cleome gynandra on Ehrlich's Ascites Carcinoma treated mice.
Bala A; Kar B; Haldar PK; Mazumder UK; Bera S
J Ethnopharmacol; 2010 May; 129(1):131-4. PubMed ID: 20307641
[TBL] [Abstract][Full Text] [Related]
6. Saccharomyces cerevisiae, the Baker's Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice.
Ghoneum M; Badr El-Din NK; Noaman E; Tolentino L
Cancer Immunol Immunother; 2008 Apr; 57(4):581-92. PubMed ID: 17891396
[TBL] [Abstract][Full Text] [Related]
7. Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)-acetamides against Ehrlich Ascites Carcinoma.
Raghavendra NM; Gurubasavarajaswamy PM; Nagaranavile KS; Parameshwaran T
Arch Pharm Res; 2009 Mar; 32(3):431-6. PubMed ID: 19387588
[TBL] [Abstract][Full Text] [Related]
8. Antioxidant potential by arabinoxylan rice bran, MGN-3/biobran, represents a mechanism for its oncostatic effect against murine solid Ehrlich carcinoma.
Noaman E; Badr El-Din NK; Bibars MA; Abou Mossallam AA; Ghoneum M
Cancer Lett; 2008 Sep; 268(2):348-59. PubMed ID: 18554778
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity and antioxidant role of Bauhinia racemosa against Ehrlich ascites carcinoma in Swiss albino mice [corrected].
Gupta M; Mazumder UK; Kumar RS; Kumar TS
Acta Pharmacol Sin; 2004 Aug; 25(8):1070-6. PubMed ID: 15301742
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity in the culture supernatant fluid of Fusobacterium nucleatum strain KO-31.
Tamai K; Nakao J; Nakagawa K; Watanabe K; Sakashita H; Nishiwaki Y; Nakashin T
Jpn J Exp Med; 1983 Oct; 53(5):251-6. PubMed ID: 6433084
[TBL] [Abstract][Full Text] [Related]
11. In vivo tumor inhibitory effects of nutritional rice bran supplement MGN-3/Biobran on Ehrlich carcinoma-bearing mice.
Badr El-Din NK; Noaman E; Ghoneum M
Nutr Cancer; 2008; 60(2):235-44. PubMed ID: 18444156
[TBL] [Abstract][Full Text] [Related]
12. Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents.
El-Far M; Elmegeed GA; Eskander EF; Rady HM; Tantawy MA
Eur J Med Chem; 2009 Oct; 44(10):3936-46. PubMed ID: 19447526
[TBL] [Abstract][Full Text] [Related]
13. Isolation, purification and antitumor activity of lipopolysaccharide from cow placenta.
Li H; Lu X; Lu M; Liu H
Int J Biol Macromol; 2008 Oct; 43(3):232-7. PubMed ID: 18582932
[TBL] [Abstract][Full Text] [Related]
14. Antitumor organometallics. I. Activity of some diphenyltin(IV) and diphenylantimony(III) derivatives on in vitro and in vivo Ehrlich ascites tumor.
Bara A; Socaciu C; Silvestru C; Haiduc I
Anticancer Res; 1991; 11(4):1651-5. PubMed ID: 1836124
[TBL] [Abstract][Full Text] [Related]
15. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
Ghosh P; Bag SP; Sur B; Sur P
Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
[TBL] [Abstract][Full Text] [Related]
16. Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate.
Chakraborty P; Sk UH; Bhattacharya S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):971-80. PubMed ID: 19221751
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Hep2 and HeLa cell proliferation in vitro and EAC tumor growth in vivo by Lapemis curtus (Shaw 1802) venom.
Karthikeyan R; Karthigayan S; Sri Balasubashini M; Somasundaram ST; Balasubramanian T
Toxicon; 2008 Jan; 51(1):157-61. PubMed ID: 17936322
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
Ghosh M; Dutta S; Sanyal U
Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605
[TBL] [Abstract][Full Text] [Related]
19. Direct antitumor effect of cepharanthin and combined effect with adriamycin against Ehrlich ascites tumor in mice.
Asaumi J; Nishikawa K; Matsuoka H; Iwata M; Kawasaki S; Hiraki Y; Nishijima K
Anticancer Res; 1995; 15(1):67-70. PubMed ID: 7733643
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]